| 95% CrI | Probability that Etoricoxib 30 mg Shows Small, Moderate or Large Improvement Relative to Comparator* | |||||
|---|---|---|---|---|---|---|
| Comparator (mg) | ES** | Low | High | Small | Moderate | Large |
| acetaminophen 4000 | -0.57 | -0.80 | -0.34 | 1.00 | 0.73 | 0.03 |
| nsNSAIDs | ||||||
| naproxen 1000 | -0.27 | -0.48 | -0.05 | 0.73 | 0.02 | 0.00 |
| ibuprofen 2400 | -0.25 | -0.53 | 0.03 | 0.65 | 0.04 | 0.00 |
| diclofenac 150 | -0.17 | -0.41 | 0.08 | 0.39 | 0.00 | 0.00 |
| COX-2 selective NSAIDs | ||||||
| celecoxib 100 | -0.55 | -0.81 | -0.29 | 0.99 | 0.65 | 0.03 |
| celecoxib 200 | -0.32 | -0.50 | -0.14 | 0.91 | 0.02 | 0.00 |
| celecoxib 400 | -0.39 | -0.62 | -0.15 | 0.94 | 0.17 | 0.00 |
| lumiracoxib 100 | -0.36 | -0.59 | -0.12 | 0.91 | 0.11 | 0.00 |
| lumiracoxib 200 | -0.39 | -0.62 | -0.15 | 0.94 | 0.17 | 0.00 |
| lumiracoxib 400 | -0.36 | -0.60 | -0.13 | 0.92 | 0.13 | 0.00 |